08.03.15: Check out my latest article to find out why I was cautious and recommended the sale of LinkedIn (LNKD) ahead of its second-quarter earnings report.
07.31.15: When a company releases earnings, there are several individual characteristics that need to be considered when you are evaluating the report.
07.31.15: Envision Healthcare's (EVHC) solid earnings have pushed the stock beyond our $44 target, but I see further upside potential here and am raising our target.
07.31.15: As promised, I wanted to follow up on last night's post on WageWorks (WAGE) after listening to the company's conference call.
07.31.15: There's a lot going on in biotech right now, which means there are plenty of opportunities worth looking into.